Molecular methods for detecting t(11;14) translocations in mantle-cell lymphomas

被引:24
作者
Fan, HX
Gulley, ML
Gascoyne, RD
Horsman, DE
Adomat, SA
Cho, CG
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA
[2] Audie L Murphy Mem Vet Hosp, San Antonio, TX 78284 USA
[3] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
关键词
mantle-cell lymphoma; bcl1; 11q13; cyclin D1; southern blot analysis; polymerase chain reaction;
D O I
10.1097/00019606-199808000-00005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The t(11;14)(q13;q32) and its molecular counterpart, bcl1/JH, are characteristic of mantle-cell lymphomas (MCL). Molecular detection of the translocation is useful in diagnosis and classification, and also shows promise in detecting minimal residual disease. The purpose of this study was to determine the frequency of detecting bcl1/JH by polymerase chain reaction (PCR) compared with Southern blot analysis in cases proven by cytogenetic analysis to harbor t(11;14). Southern blot analysis using two probes targeting the major translocation cluster (MTC) and a third probe targeting the p94 region was performed, along with PCR using two different bell MTC primers, on is cases of MCL known to have t(11;14). Southern blot analysis revealed bell rearrangement in 13 of 18 cases (72%), 12 with MTC breakpoints and 1 with a p94 breakpoint. The 2.1-kb MTC probe "b" was superior to the smaller 700-bp probe "a" in detecting these rearrangements. The MTC translocation was identified by PCR in 10 of 12 cases, and both primer sets that were tested performed equally well. This study illustrates the frequency with which molecular methods detect known t(11,14) translocations in MCLs. These results may help clinical laboratory scientists optimize their procedure for detecting bell translocations by molecular methods at initial diagnosis and for purposes of detecting minimal residual disease.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 30 条
[1]   Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease [J].
Andersen, NS ;
Donovan, JW ;
Borus, JS ;
Poor, CM ;
Neuberg, D ;
Aster, JC ;
Nadler, LM ;
Freedman, AS ;
Gribben, JG .
BLOOD, 1997, 90 (10) :4212-4221
[2]   Mantle cell lymphoma: A clinicopathologic study of 80 cases [J].
Argatoff, LH ;
Connors, JM ;
Klasa, RJ ;
Horsman, DE ;
Gascoyne, RD .
BLOOD, 1997, 89 (06) :2067-2078
[3]  
BOSCH F, 1994, BLOOD, V84, P2726
[4]  
Chhanabhai M, 1997, AM J CLIN PATHOL, V108, P295
[5]  
DEBOER CJ, 1995, ONCOGENE, V10, P1833
[6]  
DEBOER CJ, 1993, CANCER RES, V53, P4148
[7]  
DELMER A, 1995, BRIT J HAEMATOL, V89, P798
[8]   MOLECULAR-CLONING OF A T(11-14)(Q13-Q32) TRANSLOCATION BREAKPOINT CENTROMERIC TO THE BCL1-MTC [J].
GALIEGUEZOUITINA, S ;
COLLYNDHOOGHE, M ;
DENIS, C ;
MAINARDI, A ;
HILDEBRAND, MP ;
TILLY, H ;
BASTARD, C ;
KERCKAERT, JP .
GENES CHROMOSOMES & CANCER, 1994, 11 (04) :246-255
[9]  
Gulley Margaret L., 1997, Hematopathology and Molecular Hematology, V11, P1
[10]  
HARRIS NL, 1994, BLOOD, V84, P1361